Lifecore Biomedical to Exhibit at CPHI Global Conference

CHASKA, Minn., Sept. 03, 2026 /CourierPR/ -- Lifecore Biomedical, a leading contract development and manufacturing organization (CDMO) based in the United States, will participate in the CPHI Global Conference, taking place from October 6 to 8, 2026, in Milan, Italy. The company, which has over four decades of experience in the biopharmaceutical industry, will showcase its expertise in the development and manufacturing of sterile injectable pharmaceutical products.

Key figures from Lifecore, including Mark DaFonseca, Chief Commercial Officer, and business development directors Mary Evelyn Hudson, Edward Purell, and Dan Dennehy, will host meetings with potential clients to discuss process development and manufacturing services for injectable programs. Attendees can visit booth 8J60 to learn more about the company’s capabilities and meet with representatives.

Lifecore Biomedical specializes in the development, fill and finish of sterile injectable pharmaceutical products, including complex formulations in syringes, vials, and cartridges. The company is known for its premium, injectable-grade hyaluronic acid and its long-standing partnership with global and emerging biopharmaceutical and biotechnology companies across various therapeutic categories.